Search - tctmd.com

Displaying 141 - 160 of 293

Sort: Relevancy | Date

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

L.A. McKeown

June 25, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

Yael L. Maxwell

May 25, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

L.A. McKeown

May 11, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Opinion Fellow Talk

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Luai Tabaza, MD

March 11, 2020

News Industry News

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

March 05, 2020

Advertisement

Could Statins Curb Fatal or Severe COVID-19? Some Clues

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content